Willkommen bei

RONIKJA

Contraception for men

Männer können bisher nur auf ZWEI zuverlässige Verhütungsmethoden zurückgreifen:
Sterilisation und Kondom

DAS WERDEN WIR MIT ConMaCept ÄNDERN ! Hormonfrei. Sicher. Nachhaltig.
Investor weRden

ConMaCept

ConMaCept is our contraceptive product for men. It provides contraceptive protection for an entire month after only one application.

The main advantage over conventional contraceptive methods is the combination of the following properties:

  • Safety (contraception and side effects)
  • Hormone free
  • Sustainable
  • Controllability of the application
  • Low cost
ConMaCept

SpermView

SpermView ist ein Diagnostikgerät, das zur Mobilitätsanalyse der Spermien vom Mann eingesetzt werden kann.
A percentage of motile sperm is determined.
The main advantage over conventional
spermieograms is that an analysis can be performed at home:

  • Security (analysis in our app)
  • Controllability of the application
  • Low costs during use
  • Applicable at home
SpermView

Learn more...

If you are interested in our products and their current development status, please send us an e-mail. We will inform you as soon as there is something new. You can also send us a message, which we will gladly answer.

Deine Daten werden nicht an dritte weitergegeben.

Lob & Kritik der Marktanalyse

Cool concept, am curious to see more
Am very excited about the idea, thank you
Good luck people
Great idea
My only concern would be long term effects on sperm activity
Great idea! Please implement 🙂 It would be nice if you can test the device first before you buy it completely. For example, a one-time treatment in the lab or with a doctor
I would think about using it when studies have proven the safety of the procedure
Great project. I ask for quick completion. I had already thought of a mechanical valve in the vas deferens. I also find this super
My only concern would be long term effects on sperm activity
It would be important to me that the product is sufficiently tested and really does not cause any damage to the sperm quality of men in the long term.
Yes - when I read about the concept, I just thought: MEGA. Really great thing!
I must be 100% sure that the sperm can move as well as before after discontinuing the application!
Previous
Next

History

2013-2016
Idea
Idea

Idea of the development of ConMaCept. Start of development of first prototypes.

2017
Prototype I
ConMaCept I

Der erste funktionsfähige und nutzbare Prototyp.

2018
Prototype II
ConMaCept II

Prototype I is optimized.

2019
GmbH foundation
ConMaCept III

This prototype is usable for the general public.

2020
SpermView I
SpermView I

Analyze whether ConMaCept has been successfully applied. First market analysis.

2021
SW + HW Update
ConMaCept IV

Anpassung Software und Hardware

2022
SepermView II
SpermView II

Neuer Prototyp der Spermien Analyse

2023
Investoren
Investoren

Investorensuche

2024
Publication
Puplikation, Investoren

ARD, DHDL, Vorbereitung der Marktzulassung von ConMaCept

2025
clinical studies
klinische Studien UKM

ConMaCept wird für die  klinische Studie am UKM zertifiziert.

Q3 2026
ConMaCept klin. Test
ConMaCept Arzt

klinische Studie, ConMaCept wird klinisch getestet

Q4 2027
ConMaCept private use
ConMaCept käuflich

Ab Q4 2027 ist ConMaCept käuflich in EU

 

ConMaCept käuflich in USA ab Q1 2027

Scroll to Top
Scroll to Top